IP Library Granted Patent US 9,586,181
Granted Patent B2
US 9,586,181 · App. 13/177,421 · Granted Mar 7, 2017

Electrodialytic separation of CO

Inventors: Matthew D. Eisaman (Newark, CA); Karl Littau (Palo Alto, CA)
Assignee: Palo Alto Research Center Incorporated
B01D61/445C02F1/4693B01D2311/18B01D2311/2626B01D2311/2653C02F2103/08C02F2201/4618Y02C10/04Y02C10/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,586,181
App. No.
13/177,421
Granted
Mar 7, 2017
Kind
B2
Abstract

A method comprises flowing process solution and electrode solution into a BPMED apparatus, applying a voltage such that the process solution is acidified and basified and dissolved CO 2 is generated, flowing the process solution out of the apparatus, and desorbing CO 2 out of the process solution. A method for desorbing CO 2 from an ocean comprises flowing seawater and electrode solution into a BPMED apparatus, applying a voltage such that dissolved CO 2 is generated, flowing the seawater out of the apparatus, and desorbing CO 2 out of the seawater. A method for producing a desalted solution and CO 2 gas comprises flowing process solution and electrode solution into a BPMED apparatus that includes one or more three-compartment cells, applying a voltage such that the process solution is acidified, basified, and desalted, flowing the process solution out of the apparatus, and desorbing CO 2 out of the process solution.

Claims (28)

1. A method comprising:

flowing a process solution into a BPMED system with a BPMED apparatus having at least two compartments separated by membranes, wherein the process solution is one of a seawater solution, a brine or water that has absorbed gaseous CO 2 ;

flowing an electrode rinse solution into the BPMED apparatus only across electrodes in the BPMED apparatus;

applying a voltage to the BPMED apparatus and the process solution is acidified and basified, and dissolved CO 2 is generated in the acidified process solution;

flowing the acidified and basified process solution out of the BPMED apparatus;

desorbing the CO 2 out of the acidified process solution;

combining the acidified and basified process solution such that the process solution is approximately neutral pH; and

discharging the process solution from the BPMED system.

2. The method of claim 1 wherein the acidified process solution is flowed out of the BPMED apparatus and through a CO 2 desorption unit before being flowed to an acidified solution tank such that the desorbing occurs at the CO 2 desorption unit.

3. The method of claim 1 wherein the acidified process solution is flowed out of the BPMED apparatus and into an acidified solution tank such that the desorbing occurs at the acidified solution tank.

4. The method of claim 1 further comprising flowing the acidified process solution back through the BPMED apparatus to descale the BPMED apparatus.

5. The method of claim 1 wherein the BPMED apparatus comprises one or more three-compartment BPMED cells such that when the voltage is applied, the process solution is also desalted.

6. The method of claim 1 wherein a flow rate for flowing the process solution into the BPMED apparatus and a current applied by the voltage are selected such that an energy consumption of the BPMED apparatus is minimized.

7. The method of claim 6 wherein the flow rate is approximately 0.3 lpm per cell to 0.7 lpm per cell and the current density is approximately 19 mA/cm 2 to 61 mA/cm 2 .

8. The method of claim 7 wherein the flow rate is approximately 0.5 lpm per cell and the current density is approximately 22 mA/cm 2 .

9. The method of claim 7 wherein the flow rate is approximately 0.3 lpm per cell and the current is approximately 31 mA/cm 2 .

10. The method of claim 1 wherein a current applied by the voltage is selected such that the process solution is acidified to a pH that minimizes an energy consumption of the BPMED apparatus.

11. The method of claim 10 wherein the pH is approximately 3 to 6.

12. The method of claim 11 wherein the pH is approximately 4.5.

13. A method for producing a desalted solution and CO 2 gas comprising:

flowing a process solution comprised of one of seawater, a brine or water, wherein the process solution has absorbed gaseous CO 2 into a BPMED system with a BPMED apparatus, wherein the BPMED apparatus includes a membrane stack comprised of one or more three-compartment cells;

flowing an electrode rinse solution into the BPMED apparatus only across electrodes in the BPMED apparatus, the process solution and the electrode rinse solution being the only solutions used;

applying a voltage to the BPMED apparatus such that the process solution is acidified, basified, and desalted;

flowing the acidified, basified, and desalted process solution out of the BPMED apparatus;

desorbing the CO 2 out of the acidified process solution;

combining the acidified and basified process solution such that the process solution is approximately neutral pH; and

discharging the process solution from the BPMED system.

14. The method of claim 13 wherein the process solution is a seawater solution such that when the process solution is desalted, desalinated water is generated.

Assignments (7)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF US PATENTS 9356603, 10026651, 10626048 AND INCLUSION OF US PATENT 7167871 PREVIOUSLY RECORDED ON REEL 064038 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064161/0001 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064038/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2011
From: EISAMAN, MATTHEW D; LITTAU, KARL
To: PALO ALTO RESEARCH CENTER INCORPORATED
Reel/Frame 026552/0258 →
Continuity (1)
Related Publication 20130008792A1 · Jan 10, 2013